A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.

• Status: Completed
• Trial end date: 2008-11-01

Summary

This study is designed to determine if the investigational drug is effective and safe in individuals with asthma.

• Phase: Phase 2

Details

• Lead Sponsor: GlaxoSmithKline